Sarepta Therapeutics (SRPT) Free Cash Flow: 2011-2025
Historic Free Cash Flow for Sarepta Therapeutics (SRPT) over the last 15 years, with Sep 2025 value amounting to -$37.5 million.
- Sarepta Therapeutics' Free Cash Flow rose 65.25% to -$37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$381.1 million, marking a year-over-year increase of 18.98%. This contributed to the annual value of -$342.7 million for FY2024, which is 40.61% up from last year.
- As of Q3 2025, Sarepta Therapeutics' Free Cash Flow stood at -$37.5 million, which was down 116.35% from $229.5 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Free Cash Flow registered a high of $229.5 million during Q2 2025, and its lowest value of -$627.1 million during Q1 2025.
- Its 3-year average for Free Cash Flow is -$123.2 million, with a median of -$108.0 million in 2024.
- In the last 5 years, Sarepta Therapeutics' Free Cash Flow slumped by 218.27% in 2022 and then spiked by 1,713.64% in 2025.
- Over the past 5 years, Sarepta Therapeutics' Free Cash Flow (Quarterly) stood at -$31.5 million in 2021, then tumbled by 218.27% to -$100.4 million in 2022, then rose by 26.57% to -$73.7 million in 2023, then soared by 173.23% to $54.0 million in 2024, then surged by 65.25% to -$37.5 million in 2025.
- Its Free Cash Flow was -$37.5 million in Q3 2025, compared to $229.5 million in Q2 2025 and -$627.1 million in Q1 2025.